awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34949678-9E14B2D3-D98C-400A-ABF2-D222765F0A74
Q34949678-9E14B2D3-D98C-400A-ABF2-D222765F0A74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34949678-9E14B2D3-D98C-400A-ABF2-D222765F0A74
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
P2093
Q34949678-9E14B2D3-D98C-400A-ABF2-D222765F0A74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34949678-9E14B2D3-D98C-400A-ABF2-D222765F0A74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25d135e79bc9f173c76a37547eba5601b3fb611f
P1545
3
http://www.w3.org/2001/XMLSchema#string
P2093
Yan Zhuang
http://www.w3.org/2001/XMLSchema#string